Literature DB >> 26413006

Managing Heart Failure in Transposition of the Great Arteries.

Sangeeta Shah1, Tripti Gupta2, Raza Ahmad3.   

Abstract

BACKGROUND: Transposition of the great arteries (TGA) is a congenital heart defect that is associated with congestive heart failure, tricuspid regurgitation, and arrhythmias.
METHODS: This review identifies and critiques the existing methods of assessing and managing TGA with a focus on right ventricular function.
RESULTS: Echocardiography with novel strain methods and cardiac magnetic resonance imaging (MRI) are noninvasive imaging options, with cardiac MRI being the gold standard. Cardiopulmonary stress testing can be used to determine the severity of symptoms. For the medical management of right ventricular dysfunction in TGA, a closely monitored dosage of beta blockers and the concomitant use of diuretics for symptomatic relief have the strongest supporting data. Surgical options for patients with TGA include the insertion of a pacemaker to treat arrhythmias, which are more common in this population, or tricuspid valve replacement to alleviate systemic tricuspid regurgitation. If symptoms in a patient with TGA are not alleviated by these management techniques, more advanced options include the use of an Impella device (Abiomed), the insertion of ventricular assist devices, or orthotopic heart transplant.
CONCLUSION: Physicians managing patients with TGA should take a multidisciplinary specialist approach to decide which route to pursue (medical or surgical) and when more advanced treatment options are necessary.

Entities:  

Keywords:  Heart defects–congenital; heart failure; heart ventricles; transposition of great vessels; ventricular dysfunction

Year:  2015        PMID: 26413006      PMCID: PMC4569166     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  32 in total

Review 1.  Arrhythmias in adults with congenital heart disease.

Authors:  John K Triedman
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

2.  Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.

Authors:  Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2010-07       Impact factor: 5.251

3.  Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after Senning operation) or congenitally corrected transposition of the great arteries.

Authors:  Alessandro Giardini; Luigi Lovato; Andrea Donti; Roberto Formigari; Guido Oppido; Gaetano Gargiulo; Fernando Maria Picchio; Rossella Fattori
Journal:  Am J Cardiol       Date:  2006-09-14       Impact factor: 2.778

4.  Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study.

Authors:  Anne M Dubin; Jan Janousek; Edward Rhee; Margaret J Strieper; Frank Cecchin; Ian H Law; Kevin M Shannon; Joel Temple; Eric Rosenthal; Frank J Zimmerman; Andrew Davis; Peter P Karpawich; Amin Al Ahmad; Victoria L Vetter; Naomi J Kertesz; Maully Shah; Christopher Snyder; Elizabeth Stephenson; Mathias Emmel; Shubhayan Sanatani; Ronald Kanter; Anjan Batra; Kathryn K Collins
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

Review 5.  Cardiac resynchronization therapy in congenital heart disease.

Authors:  Paul Khairy; Anne Fournier; Bernard Thibault; Marc Dubuc; Johanne Thérien; Suzanne J Vobecky
Journal:  Int J Cardiol       Date:  2005-08-10       Impact factor: 4.164

6.  Systemic right ventricular longitudinal strain is reduced in adults with transposition of the great arteries, relates to subpulmonary ventricular function, and predicts adverse clinical outcome.

Authors:  Gerhard-Paul Diller; Jelena Radojevic; Aleksander Kempny; Rafael Alonso-Gonzalez; Liodakis Emmanouil; Stefan Orwat; Lorna Swan; Anselm Uebing; Wei Li; Konstantinos Dimopoulos; Michael A Gatzoulis; Helmut Baumgartner
Journal:  Am Heart J       Date:  2012-05       Impact factor: 4.749

7.  Afterload reduction therapy in patients following intraatrial baffle operation for transposition of the great arteries.

Authors:  B Robinson; C T Heise; J W Moore; J Anella; M Sokoloski; E Eshaghpour
Journal:  Pediatr Cardiol       Date:  2002 Nov-Dec       Impact factor: 1.655

8.  The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension.

Authors:  S Rich; M Seidlitz; E Dodin; D Osimani; D Judd; D Genthner; V McLaughlin; G Francis
Journal:  Chest       Date:  1998-09       Impact factor: 9.410

Review 9.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

10.  Eplerenone in systemic right ventricle: double blind randomized clinical trial. The evedes study.

Authors:  Laura Dos; Sandra Pujadas; Montserrat Estruch; Assumpta Mas; Ignacio Ferreira-González; Antònia Pijuan; Ricard Serra; Jordi Ordóñez-Llanos; Maite Subirana; Guillem Pons-Lladó; Josep R Marsal; David García-Dorado; Jaume Casaldàliga
Journal:  Int J Cardiol       Date:  2013-07-25       Impact factor: 4.164

View more
  1 in total

Review 1.  Current Knowledge and Recent Advances of Right Ventricular Molecular Biology and Metabolism from Congenital Heart Disease to Chronic Pulmonary Hypertension.

Authors:  Samantha Guimaron; Julien Guihaire; Myriam Amsallem; François Haddad; Elie Fadel; Olaf Mercier
Journal:  Biomed Res Int       Date:  2018-01-17       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.